Dr. Hind Lal, PhD, Associate Professor, Division of Cardiovascular Disease, has been appointed to serve on the Myocardial Ischemia and Metabolism (MIM) Study Section of the NIH. Members reviews grant applications in the area of basic and applied aspects of myocardial biology and cardiac metabolism. These projects involve molecular, genetic, cellular, genomic, proteomic, and physiological approaches to define the pathophysiology of myocardial biology. This prestigious appointment highlights the outstanding cardiovascular science happening at UAB.

Dr. Lal came to UAB in 2019 from Vanderbilt University Medical Center. Dr. Lal’s research seeks to understand the proteins and signaling pathways that regulate cardiac injury and heart failure. Specifically, the current investigations in his lab involve the following research projects: the signaling mechanisms of myocardial fibrosis; the mechanism of heart failure in cancer patients, and the role of GSK-3 signaling in cardio metabolic diseases.

Dr. Lal’s four year appointment to the Section became effective July 1.